Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Omicron BA.4/5 Neutralization and T-Cell Responses in Organ Transplant Recipients After Booster Messenger RNA Vaccine: A Multicenter Cohort Study.
Ferreira VH, Ierullo M, Mavandadnejad F, Kurtesi A, Hu Q, Hardy WR, Hall VG, Pinzon N, Yotis D, Gingras AC, Belga S, Shalhoub S, Hébert MJ, Humar A, Kabbani D, Kumar D. Ferreira VH, et al. Among authors: hardy wr. Clin Infect Dis. 2023 Jul 26;77(2):229-236. doi: 10.1093/cid/ciad175. Clin Infect Dis. 2023. PMID: 36975097
Differential serum neutralisation of omicron sublineages in patients receiving prophylaxis with tixagevimab-cilgavimab.
Solera JT, Arbol BG, Ferreira VH, Kurtesi A, Hu Q, Ierullo M, Valverde-Zuniga A, Raslan I, Nasir A, Grizales C, Hardy WR, Kulasingam V, Gingras AC, Humar A, Kumar D. Solera JT, et al. Among authors: hardy wr. Lancet Infect Dis. 2023 May;23(5):528-530. doi: 10.1016/S1473-3099(23)00208-6. Epub 2023 Apr 5. Lancet Infect Dis. 2023. PMID: 37030318 Free PMC article. No abstract available.
Omicron variant neutralizing antibodies following BNT162b2 BA.4/5 versus mRNA-1273 BA.1 bivalent vaccination in patients with end-stage kidney disease.
Yau K, Kurtesi A, Qi F, Delgado-Brand M, Tursun TR, Hu Q, Dhruve M, Kandel C, Enilama O, Levin A, Jiang Y, Hardy WR, Yuen DA, Perl J, Chan CT, Leis JA, Oliver MJ, Colwill K, Gingras AC, Hladunewich MA. Yau K, et al. Among authors: hardy wr. Nat Commun. 2023 Sep 27;14(1):6041. doi: 10.1038/s41467-023-41678-9. Nat Commun. 2023. PMID: 37758707 Free PMC article.
Comparison of Omicron breakthrough infection versus monovalent SARS-CoV-2 intramuscular booster reveals differences in mucosal and systemic humoral immunity.
Nantel S, Sheikh-Mohamed S, Chao GYC, Kurtesi A, Hu Q, Wood H, Colwill K, Li Z, Liu Y, Seifried L, Bourdin B, McGeer A, Hardy WR, Rojas OL, Al-Aubodah TA, Liu Z, Ostrowski MA, Brockman MA, Piccirillo CA, Quach C, Rini JM, Gingras AC, Decaluwe H, Gommerman JL. Nantel S, et al. Among authors: hardy wr. Mucosal Immunol. 2024 Apr;17(2):201-210. doi: 10.1016/j.mucimm.2024.01.004. Epub 2024 Jan 24. Mucosal Immunol. 2024. PMID: 38278415 Free article.
Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune-mediated inflammatory diseases.
Dayam RM, Law JC, Goetgebuer RL, Chao GY, Abe KT, Sutton M, Finkelstein N, Stempak JM, Pereira D, Croitoru D, Acheampong L, Rizwan S, Rymaszewski K, Milgrom R, Ganatra D, Batista NV, Girard M, Lau I, Law R, Cheung MW, Rathod B, Kitaygorodsky J, Samson R, Hu Q, Hardy WR, Haroon N, Inman RD, Piguet V, Chandran V, Silverberg MS, Gingras AC, Watts TH. Dayam RM, et al. Among authors: hardy wr. JCI Insight. 2022 Jun 8;7(11):e159721. doi: 10.1172/jci.insight.159721. JCI Insight. 2022. PMID: 35471956 Free PMC article.
Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B.
Liu J, Budylowski P, Samson R, Griffin BD, Babuadze G, Rathod B, Colwill K, Abioye JA, Schwartz JA, Law R, Yip L, Ahn SK, Chau S, Naghibosadat M, Arita Y, Hu Q, Yue FY, Banerjee A, Hardy WR, Mossman K, Mubareka S, Kozak RA, Pollanen MS, Martin Orozco N, Gingras AC, Marcusson EG, Ostrowski MA. Liu J, et al. Among authors: hardy wr. Sci Adv. 2022 Jan 21;8(3):eabj9815. doi: 10.1126/sciadv.abj9815. Epub 2022 Jan 19. Sci Adv. 2022. PMID: 35044832 Free PMC article.
63 results